Vaccine Information Statements |
|
|
|
|
|
Up-to-date translations |
|
|
|
| You
are encouraged to distribute the current English version at the same time as the translation. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Out-of-date translations |
|
|
|
| The translations for
some VISs on our website are from previously published English-language
versions that have since been updated. Unfortunately, IAC is not always
able to obtain translations as updates are issued. Please ensure that your
patients receive information consistent with the current of
the following VISs. |
|
|
| CHINESE TRANSLATION OF THE JANUARY 10, 2007 CHICKENPOX VIS |
|
|
|
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
Information was added about MMRV vaccine, tied to the March 14 MMWR, regarding increased risk of certain adverse events, including febrile seizures, with MMRV when compared with MMR and varicella vaccines given separately. Aside from two boxes containing information about MMRV, both VISs are identical to the previous editions. |
|
|
|
| • |
|
The new VISs should be used when MMRV is given; but the existing stocks of the individual MMR and varicella VISs may be used when the vaccines are given separately. |
|
|
|
| CHINESE TRANSLATION OF THE FEBRUARY 22, 2012 HPV (GARDASIL) VIS |
|
|
|
|
|
|
| This translation does not contain the following
CDC update: |
|
| • |
|
These translations do not contain the following CDC update:
The pregnancy registry for Gardasil has been terminated by the manufacturer. Consequently, the reference to the registry has
been removed from Section 4 of the Gardasil VIS. Minor wording changes throughout. Stocks of the previous VIS may still be
used as long as patients are made aware that the registry no longer exists. The updated VIS has an edition date of 5/17/13. |
|
|
|
| CHINESE TRANSLATION OF THE MARCH 1, 2010 JAPANESE ENCEPHALITIS
VIS |
|
|
|
|
|
|
| This translation does not contain the following
CDC update: |
|
| • |
|
The updated VIS reflects the fact that Ixiaro is now the only available vaccine for Japanese encephalitis. Minor changes
concern patients younger than 17 (who can no longer be advised to get JE-VAX) and recommendations for booster doses. See the
Note to Providers (also accessible from the main VIS page) for more information on these topics. Existing stocks of the
previous (3/1/10) Ixiaro VIS may still be used, although it refers to JE-VAX as still being available. |
|
A-Z
